Résumé
Contexte
La mise à jour de ces recommandations a été élaborée par la Fédération nationale des centres de lutte contre le cancer (FNCLCC) en partenariat avec les secteurs public, privé et l’Institut national du cancer.
Objectif
Actualiser les recommandations du chapitre «Traitement chirurgical» issu du rapport intégral validé en 1999.
Méthods
L’actualisation des Standards, Options: Recommandations (SOR) repose sur une revue et une analyse critique des données scientifiques disponsibles et sur le jugement argumenté des experts au sein d’un groupe de travail représentatif des modes et lieux d’exercice et des disciplines concernées par la prise en charge des patients atteints de cancer.
Résultats
Cet article présente les recommandations SOR 2007 relatives au traitement chirurgical des stades précoces et des stades avancés, établies à l’issue du processus d’actualisation.
Abstract
Context
The French federation of comprehensive cancer centres (FNCLCC) initiated the update of these recommendations in collaboration with the French national cancer institute and with specialists from French public universities, general hospitals and private clinics.
Objectives
To update the recommendations of the “surgical treatment” chapter in the complete report validated in 1999.
Methods
The guideline updating process is based on a systematic literature review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery. The Standards, Options: Recommendations are thus based on the best available evidence and expert agreement.
Results
This article presents the 2007 updated recommendations concerning the surgical treatment of early-stage and advanced-stage epithelial ovarian cancers.
Références
Aletti GD, Dowdy SC, Gostout BS, et al. (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107: 77–85
Aletti GD, Dowdy SC, Podratz KC, et al. (2006) Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced-stage ovarian cancer. Gynecol Oncol 100: 283–287
Angioli R, Palaia I, Zullo MA, et al. (2006) Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 100: 455–461
Bristow RE, Chi DS (2006) Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol 103: 1070–1076
Bristow RE, Tomacruz RS, Armstrong DK, et al. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248–1259
Chan JK, Munro EG, Cheung MK, et al. (2007) Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109: 12–19
Chan JK, Urban R, Hu JM, et al. (2007) The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients. Br J Cancer 96: 1817–1822
Chi DS, bu-Rustum NR, Sonoda Y, et al. (2005) The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol 192: 1614–1619
Chi DS, Eisenhauer EL, Lang J, et al. (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103: 559–564
Eisenhauer EL, Bu-Rustum NR, Sonoda Y, et al. (2006) The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer. Gynecol Oncol 103: 1083–1090
Eisenkop SM, Spirtos NM, Friedman RL, et al. (2003) Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 90: 390–396
Fagotti A, Fanfani F, Ludovisi M, et al. (2005) Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol 96: 729–735
Fervers B, Bonichon F, Demard F, et al. (1995) Methodology of the development of diagnostic and therapeutic standards, options and recommendations in oncology. Bull Cancer 82: 761–767
Fervers B, Hardy J, Blanc-Vincent MP, et al. (2001) SOR: project methodology. Br J Cancer 84(Suppl 2): 8–16
Ghezzi F, Cromi A, Uccella S, et al. (2007) Laparoscopy versus laparotomy for the surgical management of apparent early-stage ovarian cancer. Gynecol Oncol 105: 409–413
Giannopoulos T, Butler-Manuel S, Taylor A, et al. (2006) Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma. Eur J Gynaecol Oncol 27: 25–28
Hou JY, Kelly MG, Yu H, et al. (2007) Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 105: 211–217
Kayikcioglu F, Kose MF, Boran N, et al. (2001) Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma. Int J Gynecol Cancer 11: 466–470
Le T, Adolph A, Krepart GV, et al. (2002) The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 85: 351–355
Leblanc E, Querleu D, Narducci F, et al. (2004) Laparoscopic restaging of early-stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol 94: 624–629
Lecuru F, Desfeux P, Camatte S, et al. (2006) Impact of initial surgical access on staging and survival of patients with stage I ovarian cancer. Int J Gynecol Cancer 16: 87–94
Lecuru F, Desfeux P, Camatte S, et al. (2004) Stage I ovarian cancer: comparison of laparoscopy and laparotomy on staging and survival. Eur J Gynaecol Oncol 25: 571–576
Lee SJ, Kim BG, Lee JW, et al. (2006) Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer that is inadequate for optimum primary surgery. J Obstet Gynaecol Res 32: 99–106
Maggioni A, Benedetti PP, Dell’Anna T, et al. (2006) Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95: 699–704
Medeiros LR, Rosa DD, Bozzetti MC, et al. (2005) Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. (Protocol) Cochrane Database Syst Rev Issue 3. Art. No.: CD005344. doi: 10.1002/14651858
Morice P, Joulie F, Camatte S, et al. (2003) Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 197: 198–205
Morice P, Leblanc E, Rey A, et al. (2005) Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des chirurgiens de centre de lutte contre le cancer) and SFOG (Société française d’oncologie gynécologique). Hum Reprod 20: 1379–1385
Morice P, Wicart-Poque F, Rey A, et al. (2001) Results of conservative treatment in epithelial ovarian carcinoma. Cancer 92: 2412–2418
Morrison J, Swanton A, Kehoe S (2007) Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev, Issue 4. Art. No.: CD005343. doi: 10.1002/14651858
National Health Service (1999) Guidance on commissioning cancer services
Panici PB, Maggioni A, Hacker N, et al. (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97: 560–566
Ramirez PT, Slomovitz BM, McQuinn L, et al. (2006) Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Gynecol Oncol 103: 888–890
Raspagliesi F, Fontanelli R, Paladini D, et al. (1997) Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg 185: 457–460
Recchia F, De FS, Rosselli M, et al. (2001) Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study. Eur J Gynaecol Oncol 22: 287–291
Rose PG, Nerenstone S, Brady MF, et al. (2004) Secondary surgical cytoreduction for advanced-ovarian carcinoma. N Engl J Med 351: 2489–2497
Schilder JM, Thompson AM, DePriest PD, et al. (2002) Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 87: 1–7
SIGN (2003) Epithelial Ovarian Cancer. A national clinical guideline, 36 p. (SIGN publication; no 75)
Skirnisdottir I, Sorbe B (2007) Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III–IV) epithelial ovarian carcinoma. Int J Oncol 30: 727–734
Spirtos NM, Eisekop SM, Boike G, et al. (2005) Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol 193: 1645–1649
Stoeckle E, Paravis P, Floquet A, et al. (2004) Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer 14: 779–787
Tangjitgamol S, Manusirivithaya S, Lumbiganon P, et al. (2006) Interval debulking surgery for advanced epithelial ovarian cancer. (Protocol) Cochrane Database Syst Rev Issue 2. Art. No.: CD006014. doi: 10.1002/14651858
Tate S, Hirai Y, Takeshima N, et al. (2005) CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma. Gynecol Oncol 96: 143–149
Tozzi R, Kohler C, Ferrara A, et al. (2004) Laparoscopic treatment of early-ovarian cancer: surgical and survival outcomes. Gynecol Oncol 93: 199–203
Trimbos JB, Vergote I, Bolis G, et al. (2003) Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95: 113–125
Wimberger P, Lehmann N, Kimmig R, et al. (2007) Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 106: 69–74
Zanetta G, Chiari S, Rota S, et al. (1997) Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 104: 1030–1035
Zanetta G, Rota S, Chiari S, et al. (1998) The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Ann Oncol 9: 1097–1101
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Morice, P., Planchamp, F., Daraï, E. et al. Recommandations pour la pratique clinique: Standards, Options: Recommandations 2007 pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l’ovaire. Traitement chirurgical (rapport abrégé). Oncologie 10, 283–288 (2008). https://doi.org/10.1007/s10269-008-0849-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-008-0849-8
Mots clés
- Tumeurs épithéliales de l’ovaire
- Stades précoces
- Stades avancés
- Chirurgie
- Recommandations pour la pratique clinique